Federal drug regulators cautious about expanding use of Eli Lilly's antidepressant Cymbalta | NJ.com
Links shared publicly online about this topic.
- 940total visits
Federal drug regulators cautious about expanding use of Eli Lilly's antidepressant Cymbalta | NJ.com
nj.com —
Eli Lilly has been trying to gain approval for pain more than two years. The company withdrew its FDA application in November 2008 after agency evaluators questioned the method and design of some of the company's trials. The drug is already approved to treat depression, diabetic nerve pain and fibromyalgia.
View full resource at nj.com
Tags: Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, Drug, Cymbalta, Eli Lilly and Company
Most Recently Shared on August 17, 2010 at 10:58 pm By:
Federal drug regulators cautious about expanding use of Eli Lilly's antidepressant Cymbalta: Eli Lilly has been tr... http://bit.ly/9b9cv4
Advertisement
